Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand
Thailand’s Food and Drug Administration has approved Sinovac Biotech Ltd.’s Covid-19 vaccine for local emergency use ahead of the launch of a national inoculation program.
Thai FDA Secretary-General Paisarn Dunkum signed the emergency use approval on Monday ahead of the arrival of the first batch of 2 million doses of Sinovac shots ordered by Thailand on Wednesday. The authorization for Sinovac’s jabs is valid for one year, according to the approval letter by the drug regulator.
Thailand, which aims to inoculate 50% of its population by the end of this year, has already approved AstraZeneca Plc’s Covid-19 vaccine for emergency use. The Southeast Asian nation has ordered 61 million doses of AstraZeneca vaccine, which will be produced locally by Siam Bioscience Ltd. through technology transfer.
Enter your email to get our daily newsletter in your inbox
- The government, when it launched its vaccination programme on January 16, ensured that army personnel involved in active duty also get vaccinated as the nation in its first phase had decided to inoculate healthcare workers as well as frontline workers.
- These lawmakers are trying to address vaccine hesitancy which medical experts and lawmakers believe may impact the vaccination drive.
- Interim clinical efficacy of India-made Covaxin is 81%, says Bharat Biotech